Keybanc Maintains Overweight on Elanco Animal Health, Raises Price Target to $30
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $29 to $30.
Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $29 to $30.